COSMO PHARMACEUTICALS NV (C43.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:C43 - NL0011832936 - Common Stock
48.8 EUR
-1.2 (-2.4%)
We assign a fundamental rating of 8 out of 10 to C43. C43 was compared to 54 industry peers in the Pharmaceuticals industry. C43 gets an excellent profitability rating and is at the same time showing great financial health properties. An interesting combination arises when we look at growth and value: C43 is growing strongly while it also seems undervalued. C43 also has an excellent dividend rating. These ratings could make C43 a good candidate for value and dividend and growth and quality investing.
1. Profitability
1.1 Basic Checks
- In the past year C43 was profitable.
- C43 had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: C43 reported negative net income in multiple years.
- Each year in the past 5 years C43 had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 20.60%, C43 belongs to the best of the industry, outperforming 94.23% of the companies in the same industry.
- C43 has a better Return On Equity (26.74%) than 76.92% of its industry peers.
- With an excellent Return On Invested Capital value of 21.60%, C43 belongs to the best of the industry, outperforming 88.46% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.6% | ||
| ROE | 26.74% | ||
| ROIC | 21.6% |
ROA(3y)6.94%
ROA(5y)4.44%
ROE(3y)9.26%
ROE(5y)6.02%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- C43 has a Profit Margin of 49.94%. This is amongst the best in the industry. C43 outperforms 98.08% of its industry peers.
- In the last couple of years the Profit Margin of C43 has grown nicely.
- C43's Operating Margin of 55.81% is amongst the best of the industry. C43 outperforms 100.00% of its industry peers.
- In the last couple of years the Operating Margin of C43 has grown nicely.
- C43 has a Gross Margin of 83.00%. This is amongst the best in the industry. C43 outperforms 86.54% of its industry peers.
- In the last couple of years the Gross Margin of C43 has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 55.81% | ||
| PM (TTM) | 49.94% | ||
| GM | 83% |
OM growth 3Y48.45%
OM growth 5YN/A
PM growth 3Y14.46%
PM growth 5YN/A
GM growth 3Y18.94%
GM growth 5Y6.74%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so C43 is creating value.
- C43 has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for C43 has been increased compared to 5 years ago.
- Compared to 1 year ago, C43 has an improved debt to assets ratio.
2.2 Solvency
- C43 has an Altman-Z score of 5.80. This indicates that C43 is financially healthy and has little risk of bankruptcy at the moment.
- C43's Altman-Z score of 5.80 is amongst the best of the industry. C43 outperforms 90.38% of its industry peers.
- The Debt to FCF ratio of C43 is 0.01, which is an excellent value as it means it would take C43, only 0.01 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 0.01, C43 belongs to the best of the industry, outperforming 98.08% of the companies in the same industry.
- A Debt/Equity ratio of 0.00 indicates that C43 is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.00, C43 belongs to the top of the industry, outperforming 94.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | 5.8 |
ROIC/WACC2.81
WACC7.68%
2.3 Liquidity
- C43 has a Current Ratio of 4.19. This indicates that C43 is financially healthy and has no problem in meeting its short term obligations.
- C43's Current ratio of 4.19 is amongst the best of the industry. C43 outperforms 96.15% of its industry peers.
- C43 has a Quick Ratio of 3.91. This indicates that C43 is financially healthy and has no problem in meeting its short term obligations.
- C43 has a Quick ratio of 3.91. This is amongst the best in the industry. C43 outperforms 96.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.19 | ||
| Quick Ratio | 3.91 |
3. Growth
3.1 Past
- C43 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1315.29%, which is quite impressive.
- Measured over the past years, C43 shows a very strong growth in Earnings Per Share. The EPS has been growing by 85.20% on average per year.
- C43 shows a strong growth in Revenue. In the last year, the Revenue has grown by 187.55%.
- The Revenue has been growing by 33.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1315.29%
EPS 3Y85.2%
EPS 5YN/A
EPS Q2Q%551.15%
Revenue 1Y (TTM)187.55%
Revenue growth 3Y60.05%
Revenue growth 5Y33.68%
Sales Q2Q%165.79%
3.2 Future
- The Earnings Per Share is expected to grow by 29.02% on average over the next years. This is a very strong growth
- C43 is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.67% yearly.
EPS Next Y-23.67%
EPS Next 2Y-48.85%
EPS Next 3Y-27.68%
EPS Next 5Y29.02%
Revenue Next Year-19.4%
Revenue Next 2Y-19.53%
Revenue Next 3Y-19.24%
Revenue Next 5Y22.67%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 5.98, the valuation of C43 can be described as very cheap.
- Based on the Price/Earnings ratio, C43 is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
- C43's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
- The Price/Forward Earnings ratio is 8.09, which indicates a very decent valuation of C43.
- Based on the Price/Forward Earnings ratio, C43 is valued cheaply inside the industry as 84.62% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 24.32. C43 is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.98 | ||
| Fwd PE | 8.09 |
4.2 Price Multiples
- C43's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. C43 is cheaper than 96.15% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, C43 is valued cheaply inside the industry as 94.23% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.46 | ||
| EV/EBITDA | 3.83 |
4.3 Compensation for Growth
- The excellent profitability rating of C43 may justify a higher PE ratio.
- A cheap valuation may be justified as C43's earnings are expected to decrease with -27.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-48.85%
EPS Next 3Y-27.68%
5. Dividend
5.1 Amount
- C43 has a Yearly Dividend Yield of 3.85%. Purely for dividend investing, there may be better candidates out there.
- The stock price of C43 dropped by -28.24% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
- Compared to an average industry Dividend Yield of 1.59, C43 pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.82, C43 pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.85% |
5.2 History
- On average, the dividend of C43 grows each year by 7.41%, which is quite nice.
Dividend Growth(5Y)7.41%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- 24.09% of the earnings are spent on dividend by C43. This is a low number and sustainable payout ratio.
- C43's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP24.09%
EPS Next 2Y-48.85%
EPS Next 3Y-27.68%
COSMO PHARMACEUTICALS NV / C43.DE FAQ
What is the fundamental rating for C43 stock?
ChartMill assigns a fundamental rating of 9 / 10 to C43.DE.
What is the valuation status for C43 stock?
ChartMill assigns a valuation rating of 8 / 10 to COSMO PHARMACEUTICALS NV (C43.DE). This can be considered as Undervalued.
What is the profitability of C43 stock?
COSMO PHARMACEUTICALS NV (C43.DE) has a profitability rating of 8 / 10.
Can you provide the expected EPS growth for C43 stock?
The Earnings per Share (EPS) of COSMO PHARMACEUTICALS NV (C43.DE) is expected to decline by -23.67% in the next year.
How sustainable is the dividend of COSMO PHARMACEUTICALS NV (C43.DE) stock?
The dividend rating of COSMO PHARMACEUTICALS NV (C43.DE) is 8 / 10 and the dividend payout ratio is 24.09%.